First, distinct models of continuous hyperparathyroidism were employed: The mechanisms that control bone loss in primary hyperparathyroidism (mimicked to some degree by PTH infusion) may be different than those operant in secondary hyperparathyroidism. The gene discussed is PTH; the disease is hyperparathyroidism.